Efficacy of a Phone-based Relapse Prevention for Anorexia Nervosa After a First Hospitalization

Status: Recruiting
Location: See all (6) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Objective: To evaluate efficacy of a phone contact procedure to increase body weight at 12 months after a first hospitalization for AN, by comparison to standard medical follow-up. Secondary objectives are to evaluate effect of phone contact procedure on: change in body weight at 6 month, general psychopathology disorder, psychopathology disorder specific to AN, rate of usual follow-up visit, and medico-economic impact. Method: Prospective, multicenter, open-label, randomized controlled clinical trial, for subject over 15 years old presenting with diagnosis of AN. Patients randomized in EATLINE group will be contacted by phone at 15 days, 1, 2, 4 and 9 months after discharge from hospitalization. Patients in control group will benefit from usual follow-up. Expected outcomes and perspectives:that there will be a significant decrease in relapse due to phone contact procedure compared to control group. Results would justify additional devices at the end of hospitalization, until development of various connected tools allowing to stay in contact with patients in order to optimize the current therapeutic possibilities of AN.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 15
Healthy Volunteers: f
View:

• Subject over 15 years of age

• Diagnosis of AN (restrictive and/or purgative) according to DSM-5 criteria

• Included after a first inpatient hospitalization in specialized care

• Providing informed, dated and signed consent (for a minor, consent must be signed by both parents who have parental authority )

• With medical insurance

• Can be reached by telephone

Locations
Other Locations
France
Centre Hospitalier Général
NOT_YET_RECRUITING
Hénin-beaumont
Hôpital Fontan2, CHU
RECRUITING
Lille
Hôpital Saint Vincent de Paul, GHICL
NOT_YET_RECRUITING
Lille
Cliniqie Lautreamont
NOT_YET_RECRUITING
Loos
CHU de Montpellier
NOT_YET_RECRUITING
Montpellier
Centre Hospitalier Universitaire
NOT_YET_RECRUITING
Nantes
Contact Information
Primary
Olivier Cottencin, MD,PhD
olivier.cottencin@chru-lille.fr
3 20 44 58 38
Time Frame
Start Date: 2021-03-18
Estimated Completion Date: 2026-03
Participants
Target number of participants: 270
Treatments
Experimental: eatline group
Sham_comparator: control group
Related Therapeutic Areas
Sponsors
Collaborators: Ministry of Health, France
Leads: University Hospital, Lille

This content was sourced from clinicaltrials.gov